Phathom Pharmaceuticals (PHAT) Inventory (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Inventory for 4 consecutive years, with $7.7 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Inventory rose 124.8% year-over-year to $7.7 million; the TTM figure through Jun 2026 stood at $7.7 million (up 124.8% YoY), while the FY2025 annual figure was $5.5 million, up 72.01% from the prior year.
• Inventory rose to $7.7 million in Q2 2026 per PHAT's latest filing, from $6.5 million in the prior quarter.
• Across five years, Inventory topped out at $7.7 million in Q2 2026 and bottomed at $111000.0 in Q2 2023.
• Historically, Inventory has averaged $3.2 million across 4 years, with a median of $3.2 million in 2025.
• Annual changes were most pronounced in 2024 — Inventory jumped 2702.7% — and 2025, when it increased 16.07%.
• Phathom Pharmaceuticals' Inventory stood at $1.2 million in 2023, then surged by 165.56% to $3.2 million in 2024, then jumped by 72.01% to $5.5 million in 2025, then jumped by 39.78% to $7.7 million in 2026.
• Business Quant data shows PHAT's Inventory at $7.7 million in Q2 2026, $6.5 million in Q1 2026, and $5.5 million in Q4 2025.